Saturday, January 28, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

Kendall Leading DoD Anthrax Laboratory Review Team

by Global Biodefense Staff
June 9, 2015
DoD Anthrax Investigation - Frank Kendell

Frank Kendall (left), Deputy Defense Secretary Bob Work (center), Navy Cdr. Franca Jones (right) discuss the anthrax investigation during a briefing at the Pentagon. Image credit: Adrian Cadiz

Frank Kendall, the Department of Defense’s Undersecretary of Defense for Acquisition, Technology and Logistics, is leading a comprehensive review of DoD’s laboratory procedures, processes and protocols associated with inactivating spore-forming anthrax.

DoD Anthrax Investigation - Frank Kendell
Frank Kendall (left), Deputy Defense Secretary Bob Work (center), Navy Cdr. Franca Jones (right) discuss the anthrax investigation during a briefing at the Pentagon. Image credit: Adrian Cadiz

Speaking with Pentagon reporters last week, Kendall said he is assembling a team of government and private-sector experts to examine the anthrax spore inactivation processes.

“They will report preliminary findings and recommendations by the end of June,” he said.

According to Kendall, the final report will also depend upon the completion of the separate Center of Disease Control investigation, and will focus on two primary questions:  Why was there an incomplete inactivation of the spore-forming anthrax samples; and why testing mechanisms to ensure the procedures to inactivate the anthrax failed.

“Across the country,” Kendall said, “there are hundreds of labs that work with anthrax. As part of this mission, DoD ships inactivated or dead anthrax samples to laboratories as well as to industry, academia and other federal laboratories to help develop countermeasures and for other purposes.”

The inactivation process requires the samples to be irradiated with gamma rays, he said, then checked to ensure they are dead, and the CDC investigation is carefully examining why those two steps failed.

As part of DoD’s review of these processes, Kendall said more than 400 batches are being tested to determine how many lots were not completely inactivated.

“So far, at least four batches, or lots, have been found to have live spores present,” he said.

As additional lots are identified that were not fully inactivated, he said, labs are also being identified that received the samples, and this takes time. “So the numbers are likely to change and grow as we know more,” Kendall said.

Article adapted from original by DoD News.

Tags: AnthraxBioterrorism

Related Posts

Liverpool Synthetic Biology Lab Backed By 2M Award
Policy + Initiatives

Political Interference: White House Launches Framework to Protect Scientific Integrity

January 13, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC